Global progress toward the elimination of active trachoma: an analysis of 38 countries.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
04 2022
Historique:
received: 27 05 2021
revised: 27 01 2022
accepted: 03 02 2022
pubmed: 19 3 2022
medline: 22 4 2022
entrez: 18 3 2022
Statut: ppublish

Résumé

Global elimination of trachoma as a public health problem was targeted for 2020. We reviewed progress towards the elimination of active trachoma by country and geographical group. In this retrospective analysis of national survey and implementation data, all countries ever known to be endemic for trachoma that had either implemented at least one trachoma impact survey shown in the publicly available Trachoma Atlas, or are in Africa were invited to participate in this study. Scale-up was described according to the number of known endemic implementation units and mass drug administration implementation over time. The prevalence of active trachoma-follicular among children aged 1-9 years (TF We included data until Nov 10, 2021, for 38 countries, representing 2097 ever-endemic implementation units. Of these, 1923 (91·7%) have had mass drug administration. Of 1731 implementation units with a trachoma impact survey, the prevalence of TF Global elimination of trachoma as a public health problem by 2020 was not possible, but this finding masks the great progress achieved. Implementation units in high baseline categories and recrudescent TF None.

Sections du résumé

BACKGROUND
Global elimination of trachoma as a public health problem was targeted for 2020. We reviewed progress towards the elimination of active trachoma by country and geographical group.
METHODS
In this retrospective analysis of national survey and implementation data, all countries ever known to be endemic for trachoma that had either implemented at least one trachoma impact survey shown in the publicly available Trachoma Atlas, or are in Africa were invited to participate in this study. Scale-up was described according to the number of known endemic implementation units and mass drug administration implementation over time. The prevalence of active trachoma-follicular among children aged 1-9 years (TF
FINDINGS
We included data until Nov 10, 2021, for 38 countries, representing 2097 ever-endemic implementation units. Of these, 1923 (91·7%) have had mass drug administration. Of 1731 implementation units with a trachoma impact survey, the prevalence of TF
INTERPRETATION
Global elimination of trachoma as a public health problem by 2020 was not possible, but this finding masks the great progress achieved. Implementation units in high baseline categories and recrudescent TF
FUNDING
None.

Identifiants

pubmed: 35303459
pii: S2214-109X(22)00050-X
doi: 10.1016/S2214-109X(22)00050-X
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e491-e500

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Auteurs

Kristen K Renneker (KK)

International Trachoma Initiative, The Task Force for Global Health, Decatur, GA, USA. Electronic address: krenneker@taskforce.org.

Mariamo Abdala (M)

Mozambique Ministry of Health, Maputo, Mozambique.

James Addy (J)

Ghana Ministry of Health, Accra, Ghana.

Tawfik Al-Khatib (T)

Yemen Ministry of Health, Sana'a, Yemen.

Khaled Amer (K)

Egypt Ministry of Health, Cairo, Egypt.

Mouctar Dieng Badiane (MD)

Senegal Ministry of Health, Dakar, Senegal.

Wilfrid Batcho (W)

Benin Ministry of Health, Porto Nova, Benin.

Lucienne Bella (L)

Cameroon Ministry of Health, Yaounde, Cameroon.

Clarisse Bougouma (C)

Burkina Faso Ministry of Health, Ouagadougou, Burkina Faso.

Victor Bucumi (V)

Burundi Ministry of Health, Bujumbura, Burundi.

Tina Chisenga (T)

Zambia Ministry of Health, Lusaka, Zambia.

Tran Minh Dat (TM)

Vietnam Ministry of Health, Hanoi, Vietnam.

Djore Dézoumbé (D)

Chad Ministry of Health, N'Djamena, Chad.

Balgesa Elshafie (B)

Sudan Ministry of Health, Khartoum, Sudan.

Mackline Garae (M)

Vanuatu Ministry of Health, Port Vila, Vanuatu.

André Goepogui (A)

Guinea Ministry of Health, Conakry, Guinea.

Jaouad Hammou (J)

Morocco Ministry of Health, Rabat, Morocco.

George Kabona (G)

Tanzania Ministry of Health, Dodoma, Tanzania.

Boubacar Kadri (B)

Niger Ministry of Health, Niamey, Niger.

Khumbo Kalua (K)

Malawi Ministry of Health, Lilongwe, Malawi.

Sarjo Kanyi (S)

The Gambia Ministry of Health, Banjul, The Gambia.

Asad Aslam Khan (AA)

Pakistan Ministry of Health, Islamabad, Pakistan.

Benjamin Marfo (B)

Ghana Ministry of Health, Accra, Ghana.

Sultani Matendechero (S)

Kenya Ministry of Health, Nairobi, Kenya.

Aboulaye Meite (A)

Côte d'Ivoire Ministry of Health, Abidjan, Côte d'Ivoire.

Abdellahi Minnih (A)

Mauritania Ministry of Health, Nouakchott, Mauritania.

Francis Mugume (F)

Uganda Ministry of Health, Kampala, Uganda.

Nicholas Olobio (N)

Nigeria Ministry of Health, Abuja, Nigeria.

Fatma Juma Omar (FJ)

Zanzibar Ministry of Health, Zanzibar Town, Zanzibar.

Isaac Phiri (I)

Zimbabwe Ministry of Health, Harare, Zimbabwe.

Salimato Sanha (S)

Guinea-Bissau Ministry of Health, Bissau, Guinea-Bissau.

Shekhar Sharma (S)

Nepal Ministry of Health, Kathmandu, Nepal.

Fikre Seife (F)

Ethiopia Ministry of Health, Addis Ababa, Ethiopia.

Oliver Sokana (O)

Solomon Islands Ministry of Health, Honiara, Solomon Islands.

Raebwebwe Taoaba (R)

Kiribati Ministry of Health, Tarawa, Kiribati.

Andeberhan Tesfazion (A)

Eritrea Ministry of Health, Asmara, Eritrea.

Lamine Traoré (L)

Mali Ministry of Health, Bamako, Mali.

Naomi Uvon (N)

DR Congo Ministry of Health, Kinshasa, DR Congo.

Georges Yaya (G)

Central African Republic Ministry of Health, Bangui, Central African Republic.

Makoy Yibi Logora (MY)

South Sudan Ministry of Health, Juba, South Sudan.

P J Hooper (PJ)

International Trachoma Initiative, The Task Force for Global Health, Decatur, GA, USA.

Paul M Emerson (PM)

International Trachoma Initiative, The Task Force for Global Health, Decatur, GA, USA.

Jeremiah M Ngondi (JM)

RTI International, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH